carcinomatosis

简明释义

英[/ˌkɑːr.sɪ.nəˈmoʊ.təsɪs/]美[/ˌkɑːr.sɪ.nəˈmoʊ.təsɪs/]

n. 癌扩散，癌症

英英释义

单词用法

同义词

反义词

例句

1.Methods Analyzing the clinical data of 10 patients with meningeal carcinomatosis with their literature.

结合文献对10例脑膜癌病的临床资料进行分析。

2.Lymphangitic carcinomatosis represents intrapulmonary spread of metastatic neoplasm via lymphatics and adjacent connective tissue.

淋巴管癌病代表转移性肿瘤通过淋巴管和邻近结缔组织向肺内扩散。

3.Other proposed mechanisms include meningeal carcinomatosis with infiltration of cells into the cord and direct invasion from contiguous structures.

其他的可能机制包括脑膜癌病中癌细胞直接渗透如脊髓以及邻近结构的直接侵犯。

4.Pulmonary lymphangitic carcinomatosis (PLC) is a term that refers to tumor growth in the lymphatic system of the lungs.

肺部的癌性淋巴管炎(plc)是指肺部淋巴系统肿瘤浸润。

5.Invasion by malignant cells can cause either regional lymphadenopathy, as in patients with head and neck tumors, or generalized lymphadenopathy, as in patients with disseminated carcinomatosis.

恶性细胞侵犯可导致局部淋巴结病如在头颈部肿瘤的病人中，也可是全身性淋巴结病如在播散性癌转移的病人中。

6.Objective to investigate clinicopathological feature, diagnosis and prognosis of pulmonary lymphangitic carcinomatosis (PLC).

目的探讨肺淋巴管癌病(plc)的临床病理学特征、诊断及预后。

7.The presence of carcinomatosis can significantly decrease a patient's prognosis.

存在癌性膜病会显著降低患者的预后。

8.In cases of carcinomatosis, palliative care becomes a primary focus.

在癌性膜病的情况下，姑息治疗成为主要关注点。

9.Chemotherapy may be adjusted if carcinomatosis is detected in the patient.

如果在患者身上发现癌性膜病，化疗可能会进行调整。

10.The patient's diagnosis revealed widespread carcinomatosis, indicating advanced cancer stages.

患者的诊断显示出广泛的癌性膜病，这表明癌症已处于晚期。

11.Doctors often find carcinomatosis during imaging tests, which complicates treatment options.

医生在影像学检查中经常发现癌性膜病，这使得治疗选择变得复杂。

作文

Carcinomatosis is a medical term that refers to the widespread presence of cancerous tumors throughout the body, particularly in the organs. This condition can arise from various types of cancers and often indicates an advanced stage of disease. Understanding carcinomatosis is crucial for both patients and healthcare providers, as it significantly impacts treatment options and prognosis. When a patient is diagnosed with carcinomatosis, it usually means that the cancer has metastasized, or spread, from its original site to other parts of the body. This can happen through the bloodstream or lymphatic system, leading to the formation of secondary tumors. The symptoms of carcinomatosis can vary widely depending on the organs affected but may include pain, weight loss, fatigue, and organ dysfunction. The diagnosis of carcinomatosis typically involves imaging studies such as CT scans, MRIs, or PET scans, which can reveal the extent of tumor spread. Additionally, biopsies may be performed to confirm the presence of cancer cells in the affected areas. Early detection is vital, as it can influence treatment decisions and improve outcomes for patients. Treatment options for carcinomatosis are often limited and depend on several factors, including the type of primary cancer, the extent of spread, and the patient's overall health. Common approaches include chemotherapy, targeted therapy, immunotherapy, and palliative care. In some cases, surgical intervention may be considered to remove localized tumors, although this is less common when the cancer has spread extensively. Living with carcinomatosis can be challenging, both physically and emotionally. Patients may experience a range of feelings, from fear and anxiety to depression. Support from healthcare teams, family, and friends is essential during this difficult time. Many patients find solace in support groups where they can share their experiences and learn from others facing similar challenges. In conclusion, carcinomatosis represents a serious manifestation of cancer that requires comprehensive management. Awareness and understanding of this condition can empower patients and their families to make informed decisions about their care. As research continues to advance in the field of oncology, there is hope for more effective treatments and better outcomes for those affected by carcinomatosis. Education and support are key components in navigating the complexities of this disease, reminding us that no one should face cancer alone.

癌性腹膜转移是一个医学术语，指的是癌肿在全身，尤其是在器官中广泛存在的情况。这种情况可以由多种类型的癌症引起，通常表明疾病处于晚期。理解癌性腹膜转移对患者和医疗提供者都至关重要，因为它显著影响治疗选择和预后。当患者被诊断为癌性腹膜转移时，这通常意味着癌症已经转移或扩散，从其原始部位传播到身体的其他部分。这可以通过血液或淋巴系统发生，导致继发肿瘤的形成。癌性腹膜转移的症状因受影响的器官而异，但可能包括疼痛、体重减轻、疲劳和器官功能障碍。癌性腹膜转移的诊断通常涉及影像学检查，如CT扫描、MRI或PET扫描，这些检查可以揭示肿瘤扩散的程度。此外，可能会进行活检以确认受影响区域存在癌细胞。早期发现至关重要，因为这可以影响治疗决策并改善患者的结果。对于癌性腹膜转移的治疗选择通常有限，并取决于多个因素，包括原发癌症的类型、扩散的程度以及患者的整体健康状况。常见的方法包括化疗、靶向治疗、免疫治疗和姑息治疗。在某些情况下，可能考虑外科干预以去除局部肿瘤，尽管在癌症广泛传播时这种情况较少见。与癌性腹膜转移共存可能是一个挑战，无论是身体上还是情感上。患者可能会经历一系列情感，从恐惧和焦虑到抑郁。在这个困难时期，来自医疗团队、家人和朋友的支持至关重要。许多患者在支持小组中找到安慰，在那里他们可以分享自己的经历，并向面临类似挑战的其他人学习。总之，癌性腹膜转移代表一种严重的癌症表现，需要全面的管理。对这一情况的认识和理解可以使患者及其家属能够就其护理做出明智的决定。随着肿瘤学领域研究的不断进展，受到癌性腹膜转移影响的患者有望获得更有效的治疗和更好的结果。教育和支持是应对这一疾病复杂性的关键组成部分，提醒我们没有人应该独自面对癌症。